Neurosense Therapeutics
NRSN · NASDAQ
$2.39−$0.275 (−10.32%)TodayMarket closed ·
Prev close $2.67
Who owns NRSN
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 33.3% of NRSN’s shares.
- Ben-Noon (Alon)12.5%
- Rimon Gold Assets Ltd9.3%
- Eisenberg (Or)4.3%
- Tracik (Ferenc)1.7%
- Next 6 largest institutions5.4%
- All other shareholders66.7%
| Holder | Shares | % of shares |
|---|---|---|
| Ben-Noon (Alon) | 4.43M | 12.52% |
| Rimon Gold Assets Ltd | 3.30M | 9.34% |
| Eisenberg (Or) | 1.50M | 4.25% |
| Tracik (Ferenc) | 617.63K | 1.75% |
| Binder (Hagit) | 508.97K | 1.44% |
| Russek-Blum (Niva) | 468.50K | 1.33% |
| Leuchtenberger (Mark W) | 325.95K | 0.92% |
| Claiborne (Cary J) | 207.90K | 0.59% |
| Pellizzari (Christine) | 207.90K | 0.59% |
| Mandil-Levin (Revital Ph.D.) | 189.37K | 0.54% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 15.87K | 0.04% |
Short interest
Settled Sep 30, 2026
- Shares short
- 26.88K
- Days to cover
- 1.22
- % of shares outstanding
- 0.08%
- Average daily volume
- 22.04K
- Change since last report
- −29.7%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.